Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents.

Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents.

Item

http://www.wikidata.org/entity/Q37099271

Q37099271

about

Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and Challenges Long-term follow-up of study participants from prophylactic HIV vaccine clinical trials in Africa Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis.Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine.Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials.Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine Cryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy.Equivalence of ELISpot assays demonstrated between major HIV network laboratories Quality monitoring of HIV-1-infected and uninfected peripheral blood mononuclear cell samples in a resource-limited setting.Statistical methods for the assessment of EQAPOL proficiency testing: ELISpot, Luminex, and Flow Cytometry.Tularemia vaccines: recent developments and remaining hurdles.A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8(+) T cells with detection by ELISPOT and HLA-multimer staining Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoring.Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteers Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays Broad HIV epitope specificity and viral inhibition induced by multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults High Reproducibility of ELISPOT Counts from Nine Different Laboratories.A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults.Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adults.Non-immunogenicity of overlapping gag peptides pulsed on autologous cells after vaccination of HIV infected individuals.A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization Regimes.Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society.ELISpot for measuring human immune responses to vaccines.Enumeration and characterization of human memory T cells by enzyme-linked immunospot assays.Multiplex serum biomarker assessments: technical and biostatistical issues.Strong interferon-gamma mediated cellular immunity to scrub typhus demonstrated using a novel whole cell antigen ELISpot assay in rhesus macaques and humans.Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial.Stepping up ELISpot: Multi-Level Analysis in FluoroSpot Assays Optimizing recovery of frozen human peripheral blood mononuclear cells for flow cytometry.

P2860

Q21558500-0FDE596F-4F8D-4CD6-A95F-46672730053A Q26783884-2D7E2638-46B6-4BF5-99A9-AB9FBBF666DB Q28654629-BB8E8EF6-B814-48C9-A6BB-8BD9B6C41308 Q28744503-D1862A36-5F31-4908-BA4B-F7676002CB55 Q28749224-C0B8ACD3-A352-48F0-B0A9-3AEF48E8E54E Q30945400-2A2AC89F-0F73-4564-8445-D0394714491E Q30977303-D0CB6B49-8455-4169-AC7E-231880C9D9A7 Q33470284-2190221E-FB25-4D46-9542-E3D6621589E7 Q33527383-C8A2C7DB-8815-466E-B733-413154D525A2 Q33551527-E2E55562-30B5-43DE-9996-B2BFD225C1F9 Q33778327-59987389-9E13-48E7-8A04-D50045EDCC91 Q33909178-D75FBB93-85AA-4C18-8068-4B6330EEC717 Q33923216-222F5201-0521-4873-B35B-330C0E288284 Q34180914-7296C037-3A15-4509-BBE8-9D813977042A Q34369139-50FBBC4D-7B60-4FC9-A4BC-A8FDEBBBA7A3 Q34402469-FDA41656-27D0-41FE-917E-F8205298DFE4 Q34530756-3C3ADC39-04D3-4D3E-A753-86EE0C7325A0 Q34589611-3FA14D9B-9960-4B8B-8D36-18D4901EB475 Q34743422-C46D54FE-E405-48AC-9DE7-08012F07CFE2 Q35114907-8F681661-9700-4631-8934-F9A430DAD75A Q35237383-15080388-3F74-4828-B96C-EDB374BD77F3 Q35593139-01F5F906-CBCC-4BCF-BD6E-A2D285B9DDB7 Q35739841-033854E4-11C4-47E2-BC0E-5ACE8BF4516A Q36668517-5257AEDD-D821-41DA-95E5-C928C70057CF Q37215858-2D5C89AA-8ECD-4D55-82E2-429F35BEC097 Q37656908-39895B88-9506-43EF-AE9A-944D631FA7A4 Q37799656-58844FD0-D01B-4EFD-BBF5-D4842756CD04 Q37857243-9DD3D96E-0CD4-4168-A680-7E4D7576F799 Q38169712-2A1FCB1B-3C1B-45FA-99F3-DD287DF621AD Q38806499-BCCF7CC2-50F5-476F-AD0C-670653BCA293 Q40047668-FE51A282-2D65-4082-A166-809AE0EEDAD2 Q41926056-CC47B476-0C15-418E-9A24-0DA147A6BC2F Q42055826-567BFF02-B8C1-4984-9C95-AFF682270716 Q46956642-9D6320DD-D78F-4499-9019-F796D10DB09F

P2860

Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents.

Item

http://www.wikidata.org/entity/Q37099271

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs